| Description | Clebopride is antidopaminergic. Clebopride also has an effect of antiemetic. |
| molecular weight | 373.88 |
| Molecular formula | C20H24ClN3O2 |
| CAS | 55905-53-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: Soluble |
| References | 1. Tan Z, Ouyang D, Chen Y, Zhou G, Cao S, Wang Y, Peng X, Zhou H. Development and validation of a LC-MS/MS method for the determination of clebopride and its application to a pharmacokinetics study in healthy Chinese volunteers. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Aug 1;878(23):2072-6. doi: 10.1016/j.jchromb.2010.06.006. Epub 2010 Jun 9. PubMed PMID: 20598654. 2. Berriozabal Diaz L, Zubiaurre Lizarralde L, Castiella Eguzkiza A, Zapata Morcillo E. [Parkinsonism due to clebopride]. Rev Esp Enferm Dig. 2011 Mar;103(3):161-2. Spanish. PubMed PMID: 21434725. 3. de Lima TC, Morato GS, Loch S, Tames DR. Influence of long-term treatment of the rat with clebopride on the morphology of the mammary gland. Pharmacology. 1990;40(1):54-9. PubMed PMID: 2330385. 4. Kim KS, Shin WH, Park SJ, Kim EJ. Effect of clebopride, antidopaminergic gastrointestinal prokinetics, on cardiac repolarization. Int J Toxicol. 2007 Jan-Feb;26(1):25-31. PubMed PMID: 17365143. |